Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.

Literature DB >> 29062788

Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.

Theeratach Sriboonnark¹, Sutasinee Boonsopon¹, Nattaporn Tesavibul¹, Supinda Leeamornsiri², Pitipol Choopong¹.

Abstract

Entities: Chemical Disease

Year: 2017 PMID： 29062788 PMCID： PMC5638990 DOI： 10.18240/ijo.2017.10.25

Source DB: PubMed Journal: Int J Ophthalmol ISSN： 2222-3959 Impact factor: 1.779

× No keyword cloud information.

19 in total

1. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).

Authors: A M Abu El-Asrar; S A Al-Kharashi
Journal: Br J Ophthalmol Date: 2002-11 Impact factor: 4.638

2. Treatment of tuberculosis.

Authors:
Journal: MMWR Recomm Rep Date: 2003-06-20

3. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.

Authors: Marcus Ang; Alireza Hedayatfar; Wanling Wong; Soon-Phaik Chee
Journal: Br J Ophthalmol Date: 2011-06-30 Impact factor: 4.638

Review 4. Clinics of ocular tuberculosis.

Authors: Vishali Gupta; Samir S Shoughy; Sarakshi Mahajan; Moncef Khairallah; James T Rosenbaum; Andre Curi; Khalid F Tabbara
Journal: Ocul Immunol Inflamm Date: 2015-02 Impact factor: 3.070

5. Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis.

Authors: Roger Wong; Bhaskar Gupta; Miles R Stanford; D Alistair H Laidlaw
Journal: Int Ophthalmol Date: 2009-12-10 Impact factor: 2.031

Review 6. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Authors: Thomas A Ciulla; Philip J Rosenfeld
Journal: Curr Opin Ophthalmol Date: 2009-05 Impact factor: 3.761

Review 7. Bevacizumab (Avastin) for the treatment of ocular disease.

Authors: Jonathan B Gunther; Michael M Altaweel
Journal: Surv Ophthalmol Date: 2009 May-Jun Impact factor: 6.048

8. Unusual presentation of ocular tuberculosis: multiple chorioretinitis, retinal vasculitis and ischaemic central retinal vein occlusion.

Authors: Erdem Yuksel; Sengul Ozdek
Journal: Clin Exp Optom Date: 2013-01-16 Impact factor: 2.742